226950 — OliX Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩247bn
- KR₩261bn
- KR₩17bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14,353 | -19,385 | -30,278 | -21,888 | -19,102 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 730 | 4,219 | 7,592 | -1,945 | 3,203 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2,114 | 10,266 | 2,002 | -8,925 | -7,912 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10,733 | -3,759 | -19,054 | -30,683 | -21,168 |
Capital Expenditures | -1,078 | -1,162 | -26,285 | -2,535 | -9,068 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 13,668 | -30,258 | 41,758 | -52,229 | 43,435 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 12,590 | -31,420 | 15,473 | -54,764 | 34,366 |
Financing Cash Flow Items | -2.37 | -55.2 | -3.53 | -166 | -128 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 170 | 41,660 | 26,555 | 56,048 | -6,110 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,142 | 6,374 | 23,008 | -29,406 | 7,052 |